Atlas Trials

Ultra-Widefield Fluorescein Angiography-Based Targeted Retinal Photocoagulation Versus Conventional Panretinal Photocoagulation in the Preservation of Visual Function and Regression of Proliferative Diabetic Retinopathy

Clinical trial NCT06653361 · COMPLETED

Trial details

NCT number
NCT06653361
Sponsor
Hayatabad Medical Complex
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Proliferative Diabetic Retinopathy - High Risk
Start date
2022-09-01
Primary completion
2024-02-28
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.